Efficacy of a topical agent, MAS063D ('Atopiclair'), in the treatment of sodium lauryl sulphate-induced irritant contact dermatitis: A double-blind, vehicle-controlled study

Exogenous Dermatology

Volumn 2, Issue 6, 2003, Pages 301-305

  Zhai, Hongbo ^a,b   Villarama, Clarissa D ^a   Hafeez, Zeba Hasan ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atopiclair; Emollient; Irritant contact dermatitis; Itching; MAS063D

Indexed keywords

DODECYL SULFATE SODIUM; MAS 063D; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; IRRITANT DERMATITIS; MALE; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN COLOR; SKIN WATER LOSS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 10644273351     PISSN: 14244616     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081567     Document Type: Article

References (18)

1. Dickel H, Kuss O, Schmidt A, Kretz J, Diepgen TL: Importance of irritant contact dermatitis in occupational skin disease. Am J Clin Dermatol 2002; 3: 283-289.
2. Belsito DV, Fransway AF, Fowler JF Jr, Sherertz EF, Maibach HI, Mark JG Jr, Mathias CG, Rietschel RL, Storrs FJ, Nethercott JR: Allergic contact dermatitis to detergents: A multicenter study to assess prevalence. J Am Acad Dermatol 2002;46:200-206.
3. Kucenic MJ, Belsito DV: Occupational allergic contact dermatitis is more prevalent than irritant contact dermatitis: A 5-year study. J Am Acad Dermatol 2002;46:695-699.
4. Levin C, Maibach HI: Topical corticosteroidinduced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol 2002;3:141-147.
5. Kanerva L: Contact dermatitis; in Katsambas AD, Lotti TM (eds): European Handbook of Dermatological Treatments. Berlin, Springer, 1999, pp 117-126.
6. Zhai H, Maibach HI: Barrier creams; in Zhai H, Maibach HI (eds): Dermatotoxicology, ed 6. Boca Raton, CRC Press, 2004, pp 507-516.
7. Belloni G, Pinelli S, Veraldi S: A randomised, double-blind, vehicle-controlled study to evaluate the ef. cacy and safety of MAS063D ('Atopiclair® '), in the treatment of mild to moderate atopic dermatitis. Data on File, Sinclair Pharmaceuticals, 2004.
8. Zhai H, Chang YC, Singh M, Maibach HI: In vivo nickel allergic contact dermatitis: human model for topical therapeutics. Contact Derm 1999;40:205-208.
9. Zhai H, Simion FA, Abrutyn E, Koehler AM, Maibach HI: Screening topical antipruritics: A histamine-induced itch human model. Skin Pharmacol Appl Skin Physiol 2002;15:213-217.
10. Manuskiatti W, Maibach HI: Hyaluronic acid and skin: Wound healing and aging. Int J Derm 1996;35:539-544.
11. Galzigna L: YS 795 enzymatic inhibiting and biochemical activity. Riv Tub Mal Resp 1992;2:2-6.
12. Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R: Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera: A mechanism for their capillary protective action. Arzneimittelforsch 1994;44:592-601.
13. Calsini P, Barbacci P, Perri F, Sharifian J: 'In vitro' effects of telmesteine on scavenger pathway of alveolar macrophages and peripheral blood monocytes. Riv Tub Malat App Resp 1992;XXIV:259-265.
14. Chandler RF: Glycyrrhiza glabra ; in De Smet PAGM, Keller K, Hänsel R, Chandler RF (eds): Adverse Effects of Herbal Drugs. Berlin, Springer, 1997, vol 3.
15. Agner T, Scrup J: Sodium lauryl sulphate for patch testing: A dose-response study using bioengineering methods for determination of skin irritation. J Invest Dermatol 1990;95:543-547.
16. Beraredesca E, Maibach H: Bioengineering and the patch test. Contact Derm 2000;48:179-182.
17. Farr P, Diffey B: Quantitative studies on cutaneous erythema induced by ultraviolet radiation. Br J Dermatol 1984;111:673-682.
18. Fullerton A, Fischer T, Lahti A: Guidelines for measurement of skin colour and erythema. Contact Derm 1996;35:1-10.